Dr. Montgomery studies several important health conditions and treatments. His research includes the effects of Clostridioides difficile infections, which can cause severe diarrhea in older patients, and ways to reduce their incidence in hospital settings. He also investigates treatments for conditions like Fundic Gland Polyps and heavy menstrual bleeding in women with von Willebrand Disease. Additionally, he looks into the role of certain genetic markers in predicting the severity of COVID-19 and evaluates the safety and effectiveness of combining chemotherapy with immunotherapy for lung cancer. His findings help to improve treatment strategies and provide clarity on health risks faced by specific patient groups.
Key findings
A comprehensive strategy reduced Clostridioides difficile infection cases from 164 in 2008-09 to 37 in 2009-10, showing a 77% drop in just one year.
87.5% of severe Fundic Gland Polyps cases were found in women, with no patients developing gastric cancer in the study.
94% of women with type 1 von Willebrand Disease reported heavy menstrual bleeding, indicating a high prevalence of this symptom.
Use of the drug BAL-0028 effectively blocks the NLRP3 protein, linked to inflammation and age-related diseases, showing increased efficacy compared to existing treatments.
The research on kidney allocation indicated that using eplet mismatch significantly reduced racial disparities in matching donors to candidates, improving outcomes for Black, Asian, and Latino patients.
Frequently asked questions
Does Dr. Montgomery study infections?
Yes, he studies infections like Clostridioides difficile and their impact on older patients.
What treatments has Dr. Montgomery researched?
He has researched various treatments, including cancer therapies and hormonal treatments for heavy menstrual bleeding in women.
Is Dr. Montgomery's work relevant to women with bleeding disorders?
Yes, he specifically studies conditions like von Willebrand Disease, which causes heavy menstrual bleeding in women.
How does Dr. Montgomery's research benefit COVID-19 patients?
His research helps identify genetic factors that predict severe COVID-19 outcomes, allowing for more tailored treatments.
What is Dr. Montgomery's focus in cancer research?
He focuses on improving treatments for advanced small-cell lung cancer, exploring the safety and effectiveness of combined therapies.
Publications in plain English
Females Have a Higher Prevalence of Severe and Dysplastic Fundic Gland Polyposis: A Case-Control Study.
2026
Journal of clinical gastroenterology
Altfillisch C, Meyer C, Yuquimpo K, Jackson K, Saha S +4 more
Plain English This study looked at factors that contribute to the formation of Fundic Gland Polyps (FGPs), particularly focusing on how they might be linked to gastric cancer. Researchers found that women had a higher prevalence of severe and dysplastic FGPs—87.5% of severe cases were in women—while long-term use of stomach acid medications (PPIs) increased the risk of FGPs. Importantly, none of the patients in the study developed gastric cancer, suggesting that while FGPs are common, they might not pose an immediate cancer risk.
Who this helps: This information benefits patients, particularly women with FGPs, as it provides clarity on their condition and cancer risk.
Balancing equity and human leukocyte antigen matching in deceased-donor kidney allocation with eplet mismatch.
2025
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Mankowski MA, Gragert L, Keating B, Lonze BE, Segev DL +3 more
Plain English This study looked at how matching kidney donors and recipients by certain genetic markers affects racial fairness in organ allocation. Researchers found that using a specific type of genetic matching called eplet mismatch led to a significant decrease in racial disparities for kidney candidates: Black and Asian candidates benefited from a threefold reduction in well-matched donors, while Latino candidates saw a twofold improvement. This matters because it helps ensure that people from different racial backgrounds have a better chance of receiving suitable organ transplants.
Who this helps: This helps kidney patients from diverse racial backgrounds.
Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.
2025
Current treatment options in cardiovascular medicine
Saef J, Scandinaro A, Montgomery R, Sundaravel S, Weinreb S +11 more
Plain English This paper looks at how to improve care for adults with congenital heart disease who also face advanced heart failure. It found that while there are effective treatments for heart failure—like medications and transplant options—there's not enough research on how well these work specifically for adults with congenital heart disease. This is important because as more people with congenital heart conditions reach adulthood, better guidance and specialized care are essential for their treatment.
Who this helps: This helps patients with congenital heart disease and their healthcare providers.
Generalized Stomatal Optimization of Evolutionary Fitness Proxies for Predicting Plant Gas Exchange Under Drought, Heatwaves, and Elevated CO.
2025
Global change biology
Potkay A, Cabon A, Peters RL, Fonti P, Sapes G +7 more
Plain English This study looked at how plants manage their water loss and carbon intake through tiny openings called stomata, especially in tough conditions like drought and heatwaves. The researchers developed a new model that makes more accurate predictions about how stomata function over a plant's life, including how they respond to changes in their environment. Their model was able to predict plant stress during the 2018 European drought and showed that certain conditions could help or hurt the plants’ water efficiency.
Who this helps: This helps plant scientists and environmental researchers understand how plants may respond to climate change, which can inform conservation efforts.
An Allele of the MTHFR one-carbon metabolism gene predicts severity of COVID-19.
2025
medRxiv : the preprint server for health sciences
Petrova B, Syphurs C, Culhane AJ, Chen J, Chen E +12 more
Plain English Researchers studied how a specific gene variant related to one-carbon metabolism might help predict the severity of COVID-19 in patients. They found that individuals with two copies of the C677T allele (a common genetic variation) were more likely to experience severe illness from COVID-19 compared to others. For instance, those with this genetic marker showed a higher incidence of severe disease due to its impact on a metabolic pathway crucial for how the virus spreads in the body. This information is important because it can help identify high-risk patients earlier and guide more tailored treatments for severe COVID-19 cases.
Who this helps: This helps patients at risk of severe COVID-19 and their healthcare providers.
Documentation, Coding, and Billing for Neurologic Services and Procedures.
2025
Seminars in neurology
Busis NA, Montgomery R, Cohen BH
Plain English This study looks at how neurologists in the U.S. document, code, and bill for their services, which is essential for getting paid, sharing information, and improving patient care. It found that accurately coding diagnostics and procedures, especially using new guidelines for telemedicine, is crucial for effective practice, with a focus on improving decision-making and compliance. This matters because getting these details right not only helps neurologists sustain their practices but also ensures that patients receive better care.
Who this helps: Patients and neurologists.
All the light we cannot see: Climate manipulations leave short and long-term imprints in spectral reflectance of trees.
2025
Ecology
Stefanski A, Butler EE, Williams LJ, Bermudez R, Guzmán Q JA +5 more
Plain English This study looked at how climate change impacts trees by examining their leaves' light reflectance, which can reveal their health and responses to environmental stress. Researchers conducted experiments in northern Minnesota, measuring leaf reflectance from five tree species over three years. They found that recent stress, such as drought, leaves measurable marks on the leaves, while the conditions experienced during leaf growth have long-lasting effects, which could help scientists understand how forests respond to climate change.
Who this helps: This benefits researchers and conservationists working to protect forests and manage tree species in changing climates.
How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC.
2025
European journal of heart failure
Tocchetti CG, González A, Backs J, Pollesello P, Rainer PP +28 more
Plain English This paper looks at the challenges in turning basic heart failure research into real treatments for patients. Researchers found that there is a significant gap between the lab discoveries and their application in clinics, which often leads to new drugs failing during development. The authors emphasize the need for better communication among scientists, doctors, and the industry to speed up the creation of effective heart failure therapies.
Who this helps: Patients suffering from heart failure and the healthcare professionals treating them.
Sample size justification in feasibility studies: moving beyond published guidance.
2025
Pilot and feasibility studies
Montgomery R
Plain English This research paper looks at how researchers decide on the number of participants needed for early feasibility studies, which test whether larger follow-up trials should be done. The authors found that many of these studies don’t make strong justifications for their sample sizes, relying instead on practical reasons or basic guidelines, which can lead to unclear outcomes. They argue that it’s essential to use specific methods to ensure that these studies can accurately inform whether a future trial is likely to succeed.
Who this helps: This benefits researchers and healthcare providers planning new clinical trials.
SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.
2025
International journal of radiation oncology, biology, physics
Vargas C, Carrello J, Bressel M, Sidhom M, Lin C +12 more
Plain English This study looked at a treatment called SABR (Stereotactic Ablative Radiation Therapy) for patients with inoperable kidney cancer and compared it to two other methods: radiofrequency ablation (RFA) and cryoablation (CA). Researchers found that while patients initially experienced a drop in their quality of life after receiving SABR, this treatment was more effective and cost less over time than the other two options. Specifically, SABR was proven to be a cost-effective choice since it remained cheaper than RFA in 90% of comparisons.
Who this helps: This benefits patients with inoperable renal cell carcinoma by providing a better treatment option.
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.
2025
Research square
Langelier C, Glascock A, Maguire C, Van Phan H, Lydon E +48 more
Plain English This study looked at the effects of azithromycin, an antibiotic often given unnecessarily during COVID-19, on the respiratory health of 1,164 hospitalized patients. It found that using azithromycin changed the balance of good and bad microbes in the nose, leading to more harmful bacteria and fungi, and increased the number of resistance genes related to antibiotic effectiveness. Notably, there was no benefit in reducing inflammation from using azithromycin, despite its widespread use.
Who this helps: This research helps doctors understand the risks of prescribing azithromycin to COVID-19 patients and guides better treatment choices.
Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study.
2025
BMJ open
Parakh S, Gee H, Lim A, Vinod S, Wheeler C +14 more
Plain English This study looked at how well combining standard chemotherapy and immunotherapy with radiation works for patients with advanced small-cell lung cancer. It involved up to 35 patients, aiming to find out if this combination is safe and effective, with the goal being less than 20% experiencing severe side effects. The results are important because they could lead to better treatment options for this aggressive form of cancer if safety standards are met.
Who this helps: This helps patients with extensive-stage small-cell lung cancer by potentially improving their treatment options.
Heavy Menstrual Bleeding and Hormonal Therapy in Women with Type 1 von Willebrand Disease Enrolled on the Zimmerman Program.
2025
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Machin N, Navarrete A, Rothenberger S, Flood V, Christopherson P +3 more
Plain English This study looked at women with type 1 von Willebrand Disease (VWD), a condition that often causes heavy menstrual bleeding. Among 269 women examined, 94% reported heavy menstrual bleeding, with 47% experiencing severe symptoms. Those using hormonal therapy had slightly lower bleeding scores compared to those who weren’t using hormones, but the difference wasn’t strong enough to be considered significant.
Who this helps: This research benefits women with type 1 VWD dealing with heavy menstrual bleeding.
Reduction ofassociated disease using a multifaceted approach.
2025
Journal of infection prevention
Damani N, Montgomery R, Wallace S, Boulos A, Patterson L +1 more
Plain English The study looked at a common cause of healthcare-related diarrhea, known as Clostridioides difficile infection (CDI), which can lead to severe health issues. After implementing a comprehensive strategy to tackle this problem at Southern Health and Social Care Trust, the number of CDI cases in older patients dropped significantly from 164 cases in 2008-09 to just 37 in 2009-10, showing a 77% reduction in one year. By 2021-2022, cases continued to decline, leading to a total reduction of 64% since the initial increase.
Who this helps: This benefits older patients in hospitals who are at risk for serious infections.
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action.
2025
The Journal of experimental medicine
Wilhelmsen K, Deshpande A, Tronnes S, Mahanta M, Banicki M +30 more
Plain English Researchers studied a protein complex called NLRP3, which is linked to inflammation and several age-related diseases. They discovered a new drug, BAL-0028, which effectively inhibits NLRP3 in human cells at very low doses and shows potential against specific NLRP3 mutations involved in autoinflammatory diseases; it is more effective than the previously known drug, MCC950. These findings are important because they offer new ways to reduce inflammation in patients with diseases related to NLRP3.
Who this helps: This helps patients suffering from inflammatory diseases and their doctors in finding more effective treatments.
Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II).
2024
International journal of radiation oncology, biology, physics
Bucknell NW, Hardcastle N, Bressel M, Moore A, Montgomery R +5 more
Plain English This study compared two types of radiation therapy—one dose given at once and one spread over multiple sessions—for patients with a few small tumors in the lungs. The research involved 90 patients, and while both methods were effective, neither caused more harm than the other. At 12 months, patients experienced a decrease in lung function, with a noticeable drop in measurements like the amount of air exhaled in one second (by about 0.17 liters) and total air capacity (by about 0.20 liters), especially in those with more tumors.
Who this helps: This benefits patients with lung tumors and their doctors by providing guidance on treatment options.
Real-World Analysis of Treatment Patterns and Platinum-Based Treatment Eligibility of Patients With Metastatic Urothelial Cancer in 5 European Countries.
2024
Clinical genitourinary cancer
Milloy N, Kirker M, Unsworth M, Montgomery R, Kluth C +2 more
Plain English This study looked at how doctors in five European countries decide on treatment options for patients with advanced urothelial cancer. It found that 82% of patients received platinum-based chemotherapy as their first treatment, while only 10% were given immune checkpoint inhibitors. Understanding these treatment patterns is important since they inform how doctors make decisions and could improve patient outcomes as new therapies are developed.
Who this helps: Patients with metastatic urothelial cancer and their doctors.
Improvements in Work Productivity and Activity Impairment Among Adults With Anxiety or Depressive Symptoms Participating in a Relational Agent-Delivered Digital Mental Health Intervention.
2024
Journal of occupational and environmental medicine
Forman-Hoffman VL, Flom M, Montgomery R, Robinson A
Plain English The study looked at how a digital mental health program helped adults with anxiety or depression improve their work and daily activities. After using the program, participants saw over a 20% improvement in productivity and reduced issues from being present at work but not fully functioning, leading to potential annual cost savings of between $14,000 and $18,000. This is important because it shows that effective mental health support can positively impact not just individuals' well-being but also workplace productivity and financial outcomes.
Who this helps: This helps patients with anxiety or depression, as well as their employers.
Hospital-wide healthcare-associated carbapenemase-producing Enterobacterales outbreak: risks of electric floor scrubbers in catering facilities and kitchens.
2024
The Journal of hospital infection
Benbow A, Clarke M, Yates C, Montgomery R, Staniforth K +3 more
Plain English This study examined a serious outbreak of bacteria called carbapenemase-producing Enterobacterales (CPE) in two hospitals, focusing on how these bacteria spread, particularly through electric floor scrubbers in kitchens and catering areas. Over 19 months, 11 patients were found to be infected with a specific strain, with investigations revealing that the electric scrubbers were contaminated, contributing to the outbreak. The findings highlight how cleaning equipment can play a significant role in spreading harmful bacteria in healthcare settings, making it essential to improve cleaning practices to protect patients.
Who this helps: This benefits patients and hospital staff by improving infection control measures.
Common practices for sociodemographic data reporting in digital mental health intervention research: a scoping review.
2024
BMJ open
Kirvin-Quamme A, Kissinger J, Quinlan L, Montgomery R, Chernenok M +7 more
Plain English This study examined how well researchers reported sociodemographic information, like age and gender, in studies of app-based mental health interventions conducted between 2007 and 2022. It found that, although gender was reported in 98% of studies and age in 97%, many important categories like sexual orientation and disability status were often missing, with less than 3% reporting these details. This lack of diverse representation means we might not fully understand how effective these mental health apps are for different groups of people.
Who this helps: Patients and mental health practitioners looking for tailored digital mental health solutions.
The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening.
2024
Bioorganic & medicinal chemistry letters
Hartman G, Humphries P, Hughes R, Ho A, Montgomery R +18 more
Plain English This study focused on finding new drugs that can block a protein called NLRP3, which is involved in inflammation and cell death during the body's response to damage or infection. Researchers discovered a strong new inhibitor, known as BAL-0028, which blocks NLRP3 with a very low concentration needed to be effective (just 25 nanomolar). This discovery is important because it opens up the possibility for developing more effective treatments for conditions driven by inflammation, such as autoimmune diseases.
Who this helps: This helps patients with inflammatory diseases and their doctors by providing new treatment options.
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
2024
The Lancet. Oncology
Siva S, Bressel M, Sidhom M, Sridharan S, Vanneste BGL +21 more
Plain English This study looked at a type of radiation therapy called stereotactic ablative body radiotherapy (SABR) as a treatment for patients with primary kidney cancer who couldn't have surgery. Researchers treated 70 patients and found that 100% had their cancer controlled for at least a year after treatment, with some manageable side effects like nausea and pain affecting a small number of patients. This matters because it offers a non-surgical option for patients who might not be able to undergo surgery due to health issues, potentially improving their outcomes.
Who this helps: Patients with primary kidney cancer who are not candidates for surgery.
Momentum informed muon scattering tomography for monitoring spent nuclear fuels in dry storage cask.
2024
Scientific reports
Bae J, Montgomery R, Chatzidakis S
Plain English This study focused on improving how scientists monitor spent nuclear fuel safely stored in casks without opening them. Researchers developed a new technique called momentum-informed muon scattering tomography (MMST) that significantly enhances detection accuracy. For example, MMST boosted the accuracy of identifying missing fuel assemblies from 79% to 98% when one assembly was gone and from 51% to 88% when half was missing. This improvement is crucial for ensuring nuclear safety and security.
Who this helps: This benefits nuclear facility operators and regulatory agencies responsible for monitoring spent nuclear fuel.
A pilot study to assess blood-brain barrier permeability in long COVID.
2024
Brain imaging and behavior
Gupta A, Comfort B, Young K, Montgomery R
Plain English This study looked at whether the blood-brain barrier, which protects the brain from harmful substances, is affected in people with long COVID who experience brain fog. Researchers compared 14 long COVID patients with 10 others who didn’t have cognitive issues. They found no significant differences in the blood-brain barrier's ability to keep out substances or in cognitive test results between the two groups.
Who this helps: This research helps long COVID patients by investigating potential causes of their symptoms.
Plain English This study looked at how digital health technologies (DHTs) for neurological care are regulated in the U.S. It found that while these technologies can greatly improve patient care, obstacles like inconsistent evidence, complex coding, and varying insurance coverage make their adoption challenging. Better evaluation methods are necessary to ensure that these tools remain safe and effective while also encouraging innovation.
Who this helps: This benefits patients with neurological conditions, doctors, and healthcare policymakers.
Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for RefractoryInfection.
2024
Antibodies (Basel, Switzerland)
Ragan SA, Doyle C, Datta N, Abdic H, Wilcox MH +4 more
Plain English This study looked at how effective intravenous immunoglobulin (IVIg) is for treating patients with severe or recurring Clostridioides difficile infection (CDI), a serious gut infection. Out of 978 patients treated for CDI over five years, 20 received IVIg, and 11 of them (55%) improved with an average recovery time of 8.6 days. This finding is important because it shows that IVIg can help more than half of the patients with hard-to-treat CDI, especially those with weakened immune systems.
Who this helps: This benefits patients suffering from severe or recurrent CDI, especially those who are immunosuppressed.
Balancing Equity and HLA Matching in Deceased-Donor Kidney Allocation with Eplet Mismatch.
2024
medRxiv : the preprint server for health sciences
Mankowski MA, Gragert L, Segev DL, Montgomery R, Gentry SE +1 more
Plain English This study looked at how kidney donors are matched with recipients in the U.S. to improve transplant success rates, focusing on a new method called eplet matching. The researchers found that using eplet matching instead of traditional antigen matching can significantly reduce racial disparities; for example, the number of well-matched donors for Black and Asian candidates was three times more equitable. This approach could allow for better transplant outcomes and ensure that racial minorities have a fairer chance at receiving a matching kidney.
Who this helps: This helps kidney transplant patients, particularly those from racially diverse backgrounds.
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.
2024
Clinical transplantation
Halleck F, Böhmig GA, Couzi L, Rostaing L, Einecke G +13 more
Plain English This study compared two treatments for kidney transplant recipients facing antibody-mediated rejection: imlifidase and plasmapheresis. Researchers found that imlifidase reduced harmful antibodies in 97% of patients, while plasmapheresis only achieved a 42% reduction. However, despite this rapid reduction with imlifidase, the overall success in keeping the kidney transplant functional (graft survival) was lower at 78% compared to 89% for plasmapheresis.
Who this helps: This study benefits kidney transplant patients who experience antibody-mediated rejection.
From Silence to Sound: Graeme Clark's Cochlear Implant.
2024
Cureus
Montgomery R, Mankekar G
Plain English This research highlights the work of Graeme Clark, an Australian professor who developed the cochlear implant to help people with severe hearing loss, including his own father. His invention has benefited over 300,000 individuals globally, with more than half being children. This advancement allows those with hearing difficulties to better connect with the world around them.
Who this helps: This helps patients with profound hearing loss and their families.
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement.
2024
medRxiv : the preprint server for health sciences
Short E, Adcock IM, Al-Sarireh B, Ager A, Ajjan R +222 more
Plain English Researchers organized a large meeting with 150 experts to develop clear definitions for diseases and conditions linked to aging. They agreed on specific criteria, stating that these aging-related ailments must progress with age, lead to a decline in health, and be supported by research on humans. Establishing these definitions is crucial for improving healthcare and support systems for older adults.
Who this helps: This benefits patients, healthcare providers, and policymakers addressing the needs of aging populations.
Systematic review of conservation interventions to promote voluntary behavior change.
2023
Conservation biology : the journal of the Society for Conservation Biology
Thomas-Walters L, McCallum J, Montgomery R, Petros C, Wan AKY +1 more
Plain English This study looked at how effective various strategies are at encouraging people to adopt environmentally friendly behaviors. Researchers reviewed over 300,000 papers and found 128 quality studies to include in their analysis. Most of these studies (96 out of 128) showed positive results, particularly with education and feedback methods, suggesting that combining different types of strategies worked best. It's important to improve how we measure and report the impact of these initiatives to better protect the environment.
Who this helps: This benefits environmental organizations and policymakers focused on promoting sustainable behaviors.
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
2023
Expert review of hematology
Sidonio RF, Bryant PC, Di Paola J, Hale S, Heiman M +17 more
Plain English This study focused on understanding the research priorities for people who experience excessive bleeding from mucous membranes and skin, known as mucocutaneous bleeding (MCB). Researchers identified 38 important questions that need answering to improve diagnosis and treatment for conditions like von Willebrand disease and hereditary hemorrhagic telangiectasia. These findings are crucial because they highlight specific areas where more research is needed, which can lead to better care and support for people affected by these bleeding disorders.
Who this helps: Patients with inherited bleeding disorders and their healthcare providers.
Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study.
2023
The oncologist
Barata PC, Leith A, Ribbands A, Montgomery R, Last M +3 more
Plain English This study looked at how patients with metastatic castration-sensitive prostate cancer (mCSPC) are treated, comparing treatment methods used in 2016-2018 to those used in 2019-2020 in five European countries and the US. Researchers found that while most patients did not receive more advanced treatments, there was an increase in the use of new hormonal therapies and chemotherapy during the later years. This is important because it means that more patients are getting treatments that might help manage their condition better, but it also highlights the need for new therapies as treatment options become limited when the cancer progresses.
Who this helps: This benefits patients with metastatic prostate cancer and their doctors.
Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study.
2023
The oncologist
Barata PC, Leith A, Ribbands A, Montgomery R, Last M +3 more
Plain English This study looked at how previous treatments for metastatic castration-sensitive prostate cancer (mCSPC) affect first-line treatments for metastatic castration-resistant prostate cancer (mCRPC) in patients across five European countries and the United States. Researchers found that in Europe, 65% of patients received new hormonal therapy (NHT) and 28% received taxane chemotherapy, while in the US, the numbers were 75% and 9%, respectively. This matters because it shows that doctors are taking patients' past treatments into account when deciding how to treat mCRPC, which could improve patient outcomes.
Who this helps: This benefits patients with prostate cancer and their healthcare providers.
Extracorporeal cardiopulmonary resuscitation dissemination and integration with organ preservation in the USA: ethical and logistical considerations.
2023
Critical care (London, England)
Schiff T, Koziatek C, Pomerantz E, Bosson N, Montgomery R +2 more
Plain English This study looked at how to effectively use a life-saving technique called extracorporeal membrane oxygenation (ECMO) during cardiac arrest to improve survival rates and the quality of recovery. It found that integrating ECMO with organ preservation can help both patients who survive cardiac arrest and those who become organ donors, emphasizing the need for clear ethical guidelines and community involvement. Implementing these recommendations could lead to better outcomes in emergency care and organ donation processes.
Who this helps: Patients experiencing cardiac arrest and those in need of organ transplants.
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases.
2023
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Siva S, Sakyanun P, Mai T, Wong W, Lim A +17 more
Plain English This study looked at two different treatment methods for patients with cancer that has spread to the lungs, comparing a single session of high-dose radiation therapy to multiple sessions. After following 90 patients for about 5.4 years, researchers found that about 70% of patients were alive after 3 years, and 51% were alive after 5 years, with similar results regardless of which treatment method was used. This matters because it shows that using a single session of radiation therapy is just as effective as multiple sessions while also being more cost-effective.
Who this helps: This helps patients with lung cancer metastases by providing an effective treatment option.
On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans.
2023
JCO oncology practice
Shevach JW, Aiello LB, Lynch JA, Petersen J, Hoffman-Hogg L +11 more
Plain English This study examined how a nurse-led cancer genetics program at a Veterans Affairs clinic affected the completion of genetic testing for cancer in Black veterans. Researchers found that Black veterans who used the on-site service were 4.8 times more likely to complete the genetic testing compared to those who accessed a remote telegenetics service. This is important because it shows that local, in-person support can greatly improve health care outcomes for specific groups who may struggle with access to genetic testing.
Who this helps: This helps Black veterans seeking cancer genetic testing.
Characteristics of chief investigators and principal investigators in Australian and New Zealand radiation oncology clinical trials.
2023
Journal of medical imaging and radiation oncology
Nguyen H, Montgomery R, Sundaresan P
Plain English This study looked at the backgrounds of the main researchers in radiation oncology clinical trials in Australia and New Zealand over several years. It found that out of 134 chief investigators, only 20% were women, and 87% were from public institutions. The lack of diversity, particularly among women and researchers from rural areas, highlights a need for change to better represent and support a wide range of patients.
Who this helps: This benefits patients by promoting more inclusive research that can lead to better treatment outcomes for diverse populations.
TROG 14.04: Multicentre Study of Feasibility and Impact on Anxiety of DIBH in Breast Cancer Patients.
2022
Clinical oncology (Royal College of Radiologists (Great Britain))
Kron T, Bressel M, Lonski P, Hill C, Mercieca-Bebber R +13 more
Plain English This study looked at a method called deep inspiration breath hold (DIBH) for breast cancer patients getting radiation therapy, particularly those with left-sided tumors. It found that using DIBH cut the radiation dose to the heart from an average of 2.8 Gy to 1.5 Gy, which is almost a 50% reduction. While DIBH took about 2 additional minutes per treatment, two-thirds of the patients could successfully hold their breath for the required time, and their anxiety levels decreased over the course of treatment.
Who this helps: This helps breast cancer patients undergoing radiation therapy, especially those with left-sided tumors.
Deeply Virtual Compton Scattering Cross Section at High Bjorken x_{B}.
2022
Physical review letters
Georges F, Rashad MNH, Stefanko A, Dlamini M, Karki B +158 more
Plain English This study looked at a specific type of particle interaction called deeply virtual Compton scattering, focusing on measurements taken at high Bjorken values. The researchers found precise data that allows for a better understanding of four key factors related to how nucleons (like protons and neutrons) behave, especially under certain conditions, showing sensitivity to some factors that were not well understood before. These findings are important because they enhance our knowledge of the internal structure of nucleons, which can help improve our understanding of fundamental physics.
Who this helps: This benefits physicists and researchers studying the fundamental properties of matter.
Pretransplant Psoas Muscle Cross-Sectional Area and Postkidney Transplant Outcomes.
2022
Transplantation proceedings
Norris T, Montgomery R, Cibrik D, Reintjes M, Chakraborty S +2 more
Plain English This study looked at how the size of a specific muscle (the psoas muscle) before kidney transplant affects health outcomes after the transplant. Researchers analyzed data from 573 kidney transplant patients and found that for those receiving just a kidney (465 patients), larger psoas muscles meant shorter hospital stays, but this muscle size did not affect kidney function decline, graft loss, or death rates. This is important because it helps to understand which factors really impact recovery after a kidney transplant, allowing for better patient care planning.
Who this helps: Patients undergoing kidney transplants.
Can a Banana a Day Keep the Cancer Away in Patients with Lynch Syndrome?
2022
Cancer prevention research (Philadelphia, Pa.)
Bansal A, Montgomery R, Vilar E
Plain English This study looked at the effects of a type of fiber called resistant starch (RS) on patients with Lynch syndrome, a genetic condition that increases the risk of certain cancers, particularly colorectal cancer. The researchers found that while eating resistant starch did not reduce colorectal cancer cases, it did lower the occurrence of other related tumors, especially those in the upper digestive system. This is important because it highlights a potential dietary approach to help reduce cancer risks for patients with this genetic syndrome.
Who this helps: Patients with Lynch syndrome.
Erratum to "Outbreak of New Delhi Metallo-Beta-lactamase Carbapenemase Producing Enterobacterales on a bone marrow transplant unit: Role of the environment" Infect Prev Pract, Vol. 3 (June 2021) Article Number: 100125.
2022
Infection prevention in practice
Prescott K, Billam H, Yates C, Clarke M, Montgomery R +4 more
Plain English This article corrects details from a previous study about an outbreak of a specific type of bacteria that produces an enzyme making it resistant to many antibiotics in a bone marrow transplant unit. The study highlights how the environment played a role in this outbreak, though specific findings and numbers from the original study aren't included in this correction. Understanding these outbreaks is crucial for improving infection control and safety for vulnerable patients.
Who this helps: Patients in bone marrow transplant units.
Cost-Effectiveness of Single Versus Multifraction SABR for Pulmonary Oligometastases: The SAFRON II Trial.
2022
International journal of radiation oncology, biology, physics
Lourenco RA, Khoo T, Crothers A, Haas M, Montgomery R +3 more
Plain English This study looked at the costs and effectiveness of two types of radiation therapy for patients with a few cancer tumors in the lungs: single-fraction (SF), where patients receive one big dose, and multifraction (MF), where they get several smaller doses. Researchers found that SF therapy was cheaper, saving about A$1194 per patient, and was likely to provide better health outcomes at a cost of A$15,821 for each additional year of healthy life gained. This matters because it shows that a simpler and less expensive treatment could be just as effective, which is important for health care budgeting and patient care decisions.
Who this helps: Patients with lung cancer and their doctors.
The global spectrum of plant form and function: enhanced species-level trait dataset.
2022
Scientific data
Díaz S, Kattge J, Cornelissen JHC, Wright IJ, Lavorel S +141 more
Plain English This study created a comprehensive dataset of plant traits to better understand the variety of plant forms and functions around the world. It includes average measurements for six important traits across nearly 46,000 plant species, drawn from about 1 million records. This work is significant because it provides a reliable resource for researchers studying plant characteristics, which can help inform conservation, agriculture, and climate change strategies.
Who this helps: This benefits scientists, conservationists, and agricultural professionals.